Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Non-Current Assets (2022 - 2023)

Historic Non-Current Assets for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $27.4 million.

  • Therapeutics' Non-Current Assets fell 2450.42% to $27.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $149.5 million, marking a year-over-year change of. This contributed to the annual value of $46.5 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Non-Current Assets of $27.4 million as of Q3 2023, which was down 2450.42% from $35.9 million recorded in Q2 2023.
  • Therapeutics' 5-year Non-Current Assets high stood at $46.5 million for Q4 2022, and its period low was $27.1 million during Q2 2022.